SOUTH SAN FRANCISCO, Calif. (AP) — Calithera Biosciences Inc. (CALA) on Thursday reported a loss of $11 million in its fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 31 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.

The drug developer posted revenue of $7.3 million in the period.

For the year, the company reported that its loss narrowed to $27.8 million, or 84 cents per share. Revenue was reported as $26 million.

Calithera shares have increased slightly more than 8 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.05, a drop of 25 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CALA at

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.